Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (81-90 of 416) with videos related to

Pageof 42
Sort By:
Biomed Research International|June 28, 2014
CXC and CC chemokines as angiogenic modulators in nonhaematological tumorsMatteo Santoni, Sergio Bracarda, Massimo Nabissi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 4, 2023
Bronchoscopically-visible massive central airway cancer cavitation is associated with metastatic disease, lack of actionable mutations and poor prognosis: a case seriesDaniele Magnini, Emilio Bria, Alessandra Cancellieri, et al.
Drugs|April 3, 2026
Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical RationaleMarzia Del Re, Elvira Inglese, Emilio Bria, et al.
Biomedicines|February 25, 2022
Identification of Targetable Liabilities in the Dynamic Metabolic Profile of <i>EGFR</i>-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI ResistanceAnastasios Gkountakos, Giovanni Centonze, Emanuele Vita, et al.
Cancers|November 14, 2019
PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and TargetLisa Salvatore, Maria Alessandra Calegari, Fotios Loupakis, et al.
European Journal of Clinical Nutrition|March 28, 2018
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapyIlaria Trestini, Luisa Carbognin, Isabella Sperduti, et al.
Expert Opinion on Pharmacotherapy|February 14, 2020
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitorsGiovanna Garufi, Antonella Palazzo, Ida Paris, et al.
Cancers|October 30, 2019
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old StoryGeny Piro, Carmine Carbone, Luisa Carbognin, et al.
Anti-Cancer Drugs|April 5, 2013
Chemotherapy in metastatic renal cell carcinoma today? A systematic reviewSebastiano Buti, Melissa Bersanelli, Angelica Sikokis, et al.
Clinical Genitourinary Cancer|July 3, 2013
Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agentsFrancesco Massari, Emilio Bria, Francesca Maines, et al.
Pageof 42

Showing results (81-90 of 416) with videos related to

Sort By:
Pageof 42
Biomed Research International|June 28, 2014
CXC and CC chemokines as angiogenic modulators in nonhaematological tumorsMatteo Santoni, Sergio Bracarda, Massimo Nabissi, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|October 4, 2023
Bronchoscopically-visible massive central airway cancer cavitation is associated with metastatic disease, lack of actionable mutations and poor prognosis: a case seriesDaniele Magnini, Emilio Bria, Alessandra Cancellieri, et al.
Drugs|April 3, 2026
Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical RationaleMarzia Del Re, Elvira Inglese, Emilio Bria, et al.
Biomedicines|February 25, 2022
Identification of Targetable Liabilities in the Dynamic Metabolic Profile of <i>EGFR</i>-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI ResistanceAnastasios Gkountakos, Giovanni Centonze, Emanuele Vita, et al.
Cancers|November 14, 2019
PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and TargetLisa Salvatore, Maria Alessandra Calegari, Fotios Loupakis, et al.
European Journal of Clinical Nutrition|March 28, 2018
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapyIlaria Trestini, Luisa Carbognin, Isabella Sperduti, et al.
Expert Opinion on Pharmacotherapy|February 14, 2020
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitorsGiovanna Garufi, Antonella Palazzo, Ida Paris, et al.
Cancers|October 30, 2019
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old StoryGeny Piro, Carmine Carbone, Luisa Carbognin, et al.
Anti-Cancer Drugs|April 5, 2013
Chemotherapy in metastatic renal cell carcinoma today? A systematic reviewSebastiano Buti, Melissa Bersanelli, Angelica Sikokis, et al.
Clinical Genitourinary Cancer|July 3, 2013
Adjuvant treatment for resected renal cell carcinoma: are all strategies equally negative? Potential implications for trial design with targeted agentsFrancesco Massari, Emilio Bria, Francesca Maines, et al.
Pageof 42